athenahealth Now Covered by Analysts at Stifel Nicolaus (ATHN)
Stock analysts at Stifel Nicolaus started coverage on shares of athenahealth (NASDAQ:ATHN) in a report issued on Tuesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $155.00 price target on the stock. Stifel Nicolaus’ price target would indicate a potential upside of 20.97% from the company’s current price.
The analysts wrote, “We are initiating coverage of athenahealth, Inc., with a Buy rating on the shares and a $155.00 12-month target price. Our target equates to an enterprise value multiple of 6.7x our 2015 revenue estimate of $920.5 million. We believe athenahealth represents a cornerstone franchise within the digital healthcare industry. Through cloud-based software, networked knowledge, and value-add back-office administration, the company aims to be the caregiver’s most trusted service platform.”
Shares of athenahealth (NASDAQ:ATHN) traded up 4.43% during mid-day trading on Tuesday, hitting $133.80. 107,678 shares of the company’s stock traded hands. athenahealth has a one year low of $83.57 and a one year high of $206.70. The stock has a 50-day moving average of $121.6 and a 200-day moving average of $145.6. The company’s market cap is $5.063 billion.
athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, April 17th. The company reported $0.12 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.17 by $0.05. The company had revenue of $163.00 million for the quarter, compared to the consensus estimate of $170.03 million. During the same quarter in the prior year, the company posted $0.38 earnings per share. The company’s quarterly revenue was up 29.8% on a year-over-year basis. On average, analysts predict that athenahealth will post $1.04 earnings per share for the current fiscal year.
In other athenahealth news, Director David Eric Robinson unloaded 30,000 shares of athenahealth stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $124.12, for a total value of $3,723,600.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Several other analysts have also recently commented on the stock. Analysts at Topeka Capital Markets initiated coverage on shares of athenahealth in a research note on Thursday, June 12th. They set a “buy” rating and a $145.00 price target on the stock. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of athenahealth in a research note on Monday, May 12th. They now have a $192.00 price target on the stock. Finally, analysts at Oppenheimer cut their price target on shares of athenahealth from $120.00 to $90.00 in a research note on Wednesday, May 7th. They now have an “underperform” rating on the stock. One research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and fourteen have given a buy rating to the stock. athenahealth currently has a consensus rating of “Hold” and a consensus price target of $165.64.
athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.